Études - Cancer Ovaire

Études ovaire - En cours de recrutement


Études ovaire - En cours de lancement


Études ovaire - Recrutement terminé

(Concernant les études dont le recrutement est terminé, pour consulter la fiche descriptive de ces études vous serez dirigé sur notre site Internet d’archivage. Pour consulter les documents relatifs à ces études, il vous suffira de vous connecter avec vos identifiants habituels.)



Publications relatives aux études en rapport avec les cancers de l'ovaire - 2016

  • Étude clinique Seribantumab Article (Journal Clinical of Oncology)
    J.F. Liu
    Randomized Phase II Trial of Seribantumab in Combination with Paclitaxel in Patients with Advanced Platinum-Resistant or -Refractory Ovarian Cancer.
    Journal Clinical of Oncology - Octobre 2016 (réf. PubMed : PMID: 27998236 DOI: 10.1200/JCO.2016.67.1891 [PubMed - as supplied by publisher])
  • ESSAI AGO-OVAR-16 Article (BMC Medical Ethics)
    D.J. Pulford
    Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
    BMC Medical Ethics - Octobre 2016 (réf. PubMed : PMID: 27769273 DOI: 10.1186/s12910-016-0144-y [PubMed - as supplied by publisher])
  • ESSAI NOVA Article (Journal clinical of oncology)
    M.R. Mirza
    Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
    New England Journal of medicine - Juillet 2016 (réf. PubMed : PMID: 27717299 [PubMed - as supplied by publisher])
  • ESSAI PENELOPE Article (Journal clinical of oncology)
    C. Kurzeder
    Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE).
    Journal clinical of oncology - Juillet 2016 (réf. PubMed : PMID: 27269942 [PubMed - in process])
  • ESSAI PENELOPE Article (International J Gynecol Cancer)
    A. González-Martín
    Pertuzumab Plus Chemotherapy for Platinum-Resistant Ovarian Cancer: Safety Run-in Results of the PENELOPE Trial.
    International J Gynecol Cancer - Juin 2016 (réf. PubMed : PMID: 27206218 [PubMed - as supplied by publisher])
  • ESSAI AGO OVAR 3, 5, 7 & 9 – Article (European Journal of Cancer)
    M. Klar
    Prognostic factors in young ovarian cancer patients: An analysis of four prospective phase III intergroup trials of the AGO Study Group, GINECO and NSGO.
    European Journal of Cancer - Octobre 2016 (réf. PubMed : PMID: 27561452 [PubMed - in process])
  • ESSAI COCCINELLE – Article (Journal of Clinical Oncology)
    T. Sugiyama
    Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.
    Journal of Clinical Oncology - Août 2016 (réf. PubMed : PMID: 27400948 [PubMed - in process])
  • ESSAI AURELIA – Article (Gynecologic Oncology)
    A. Husain
    Independent radiologic review of AURELIA, a phase 3 trial of bevacizumab plus chemotherapy for platinum-resistant recurrent ovarian cancer.
    Gynecologic Oncology - Septembre 2016 (réf. PubMed : PMID: 27184721 [PubMed - in process])
  • ESSAI AURELIA – Article (Annals of Oncology)
    K. Lindemann
    Poor concordance between CA-125 and RECIST at the time of disease progression in patients with platinum-resistant ovarian cancer: analysis of the AURELIA trial.
    Annals of Oncology - Août 2016 (réf. PubMed : PMID: 27407100 [PubMed - in process])
  • ESSAI AURELIA – Article (Annals of Oncology)
    F. Trillsch
    Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial.
    Annals of Oncology - Juin 2016 (réf. PubMed : PMID: 27287207 [PubMed - as supplied by publisher])
  • ESSAIS POOLÉS FAG1 FAG2 & FAG3 – Article (Gynecologic Oncology)
    F. Tinquaut
    Prognostic factors for overall survival in elderly patients with advanced ovarian cancer treated with chemotherapy: results of a pooled analysis of three GINECO phase II trials.
    Gynecologic Oncology - Avril 2016 (réf. PubMed : PMID: 27045777 [PubMed - as supplied by publisher])
  • ESSAI POLKA – Article (Journal of Clinical Oncology)
    E. Pujade-Lauraine
    Volasertib Versus Chemotherapy in Platinum-Resistant or -Refractory Ovarian Cancer: A Randomized Phase II Groupe des Investigateurs Nationaux pour l'Etude des Cancers de l'Ovaire Study.
    Journal of Clinical Oncology - Janvier 2016 (réf. PubMed : PMID: 26755507 [PubMed - indexed for MEDLINE])
  • GERMLINE BRCA1/2 – Article (Gynecologic Oncology)
    S. Lheureux
    Germline BRCA1/2 testing practices in ovarian cancer: Current state and opportunities for new directions.
    Gynecologic Oncology - Janvier 2016 (réf. PubMed : PMID: 26475959 [PubMed - indexed for MEDLINE])
  • DICER1 & FOXL2 – Article (Histopathology)
    T. Goulvent
    DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Histopathology - Janvier 2016 (réf. PubMed : PMID: 26033501 [PubMed - in process])

Haut de page